Endo Loses Bid to Block Sales of Generic Painkiller
Saturday, May 11, 2013 - 00:10
in Health & Medicine
The agency’s decision on generic Opana ER came just weeks after it reached the opposite conclusion in the case of another frequently abused painkiller, OxyContin.